Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Early Detection of Intrahepatic Cholangiocarcinoma Crucial

By LabMedica International staff writers
Posted on 27 Jan 2010
Incidence of intrahepatic cholangiocarcinoma (ICC) is increasing worldwide and its prognosis is very poor. More...
Therefore, further studies on its clinical characteristics for early detection and on surgical treatment for better prognosis are urgently needed.

A research team from the Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai, China) retrospectively evaluated 5,311 liver cancer patients who received resection between October 1999 and December 2003. Of these, 429 (8.1%) patients were diagnosed with ICC, and their clinicopathologic, surgical, and survival characteristics were analyzed. Their study was published on December 21, 2009, in the World Journal of Gastroenterology.

The study demonstrated that hepatitis B infection, carbohydrate antigen 19-9 (CA19-9), carcinoembryonic antigen (CEA), and alpha-fetoprotein (AFP) are associated with ICC development. CA19-9 levels are associated with lymph node metastases, but inversely with cirrhosis. Radical resection (R0) is the key prognostic factor for ICC.

Future studies, according to the researchers, should focus on evaluation of the molecule-targeted therapy, and whether it can effectively control this lethal disease to improve the survival of the patients.

Related Links:

Eastern Hepatobiliary Surgery Hospital, Second Military Medical University




Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Online QC Software
Acusera 24•7
New
Automatic CLIA Analyzer
Shine i6000
New
Multi-Chamber Washer-Disinfector
WD 390
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: Researchers identified blood-based genomic signatures characteristic of inflammatory breast cancer (photo courtesy of Shutterstock)

Liquid Biopsy Biomarkers Distinguish Inflammatory Breast Cancer and Support Monitoring

Inflammatory breast cancer is among the most aggressive forms of breast malignancy and remains challenging to diagnose and monitor. Obtaining tumor tissue can be difficult, and standard genome and RNA... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.